Case Report
Recurrence of Eosinophilic Oesophagitis with Subcutaneous Grass Pollen Immunotherapy
R Wells1*, M Furman2 and A Fox1
1Department of Allergy, St Thomas’s Hospital, London
2Department of Allergy, Royal Free Hospital, London
*Corresponding author: Rosy Wells, Department of Allergy, St Thomas’s Hospital, London
Published: 05 Jan, 2017
Cite this article as: Wells R, Furman M, Fox A. Recurrence
of Eosinophilic Oesophagitis
with Subcutaneous Grass Pollen
Immunotherapy. Ann Clin Case Rep.
2017; 2: 1227.
Abstract
Case reports have described an association between both oral food immunotherapy and aeroallergen
immunotherapy with the development of Eosinophilic Oesophagitis (EoE). The underlying
mechanism of this is poorly understood, as is the possible role that both food and aeroallergen
sensitization play in the pathogenesis of EoE.
Specific Immunotherapy has a longstanding history of use in the management of moderate to severe
seasonal allergic rhinitis, caused by tree or grass pollens. Subcutaneous immunotherapy (SCIT) to
grass pollen is less commonly used in children than sublingual (SLIT) or oral immunotherapy for
practical reasons.
Here we describe a case of a child with severe grass pollen related allergic rhinitis as well as known
but quiescent EoE, who developed recurrence of oesophageal symptoms on two separate occasions
coincident with the commencement of sublingual immunotherapy (SLIT) to grass pollen. He was
subsequently started on subcutaneous immunotherapy (SCIT) to grass pollen and again developed
recurrence of symptoms of EoE – a phenomenon that has yet to be reported in the medical literature.
Background
A rise in the prevalence and recognition of EoE has been seen alongside the rise in IgE mediated
allergic disease in western countries, and concomitant allergic diseases such as asthma, allergic
rhinitis and eczema are common in children with EoE [1]. The role of IgE food sensitization in
patients with EoE is unclear but elemental diets are often used in its management with strong
evidence of success [2].
Aeroallergens have also been linked to the development of EoE. Mishra et al. [3] described
an aetiological role for aeroallergen exposure in animal models. Other studies have observed a
correlation between season and symptoms of EoE, supporting the link between aeroallergens and
the development of EoE [4-6].
Specific Immunotherapy has a longstanding history of effective use in the management
of moderate to severe seasonal allergic rhinitis, caused by tree or grass pollens when maximal
pharmacotherapy with intranasal steroids and anti-histamines has provided inadequate symptom
relief. In the UK, subcutaneous immunotherapy (SCIT) to grass pollen is less commonly used in
children than sublingual (SLIT) immunotherapy for practical reasons, but still offers an alternative
treatment option for children whom may not tolerate SLIT or for those in whom it is not tolerated,
adhered to or contraindicated.
An association between initiation of oral food immunotherapy and the development of EoE
has been reported. A systematic review by Lucendo et al. [7] found that new onset EoE developed
in up to 2.7% of patients undergoing oral immunotherapy for food allergy. Case reports have
also described the association between pollen sublingual immunotherapy and the development
of EoE [8]. However, the authors could not find any case reports in the literature describing the
development or recurrence of EoE following SCIT for anaero allergen.
Case Presentation
A 10-year-old boy was reviewed in our allergy clinic for consideration of immunotherapy
to grass pollen. He had a history of nut allergy, allergic rhinitis, atopic asthma and eosinophilic
oesophagitis.
Asthma was reported to be seasonal and was well controlled
on inhaled steroid (fluticasone 200 mcg inhaled, twice daily), with
normal spirometry.
Eosinophilic oesophagitis was diagnosed histologically at age 8
with 45 eosinophils per high power field in the lower oesophagus on
endoscopy. Symptoms were reported to be seasonal and our patient
was treated with viscous budesonide and omeprazole for flares. Skin
prick testing showed sensitization to grass pollen (12 mm), house
dust mite (7 mm) and alternaria (7 mm).
At the time of review (in the autumn), symptoms of EoE were
under control.
Seasonal allergic rhinitis was sub-optimally managed with a
nasal fluticasone furoate spray (27.5 mcg), montelukast 5 mg and
an oral antihistamine. Our patient had previously been commenced
on sublingual immunotherapy to grass pollen (5 grass mix, Staloral,
Stallergenes) on two occasions, but had been unable to tolerate
treatment due to recurrence of symptoms of EoE.
The first trial of SLIT, 10 months previously, had resulted in
abdominal pain and symptoms of reflux two hours after the first dose.
The dose was reduced and he was advised to spit out the extract after
2 minutes. Despite this, his abdominal pain and symptoms of reflux
persisted. The clinical impression was that of recurrence of EoE and
therefore the SLIT was stopped after one week. He was recommenced
on budesonide slurry for three weeks with resolution of symptoms
of EoE.
The second trial of SLIT immunotherapy was commenced two
months later on a slower up-dosing regimen with preventative
protection with viscous budesonide and omeprazole. Our patient
tolerated up-dosing to maintenance dose over 3 months but he could
not tolerate a decrease in the viscous budesonide on this dose.
The family were determined that the patient should receive
desensitization treatment, and thus he received a trial of subcutaneous
immunotherapy (SCIT) to grass pollen. The patient tolerated the first
two injections of 0.1 and 0.2ml (Allergovit, grass pollen) but developed
reflux symptoms following the third dose (0.4 ml). After the fourth
injection (0.8 ml) he developed significant vomiting, warranting
an inpatient stay in hospital and a course of oral steroids. Despite
no further SCIT, symptoms of EoE worsened over the following
month, requiring another inpatient hospital stay, further oral steroids
and elemental diet. A repeat endoscopy was not performed since
symptoms were consistent with his initial presentation of EoE and
improved with steroid treatment.
At review the following month symptoms had settled and further
immunotherapy has not been recommenced.
Discussion
The role of aeroallergens in the pathogenesis of EoE has yet to
be established. However, seasonal differences in disease prevalence
and recurrence have been reported and case reports have described
recurrence of symptoms of EoE associated with SLIT to aeroallergens.
We have described the first case in the literature of recurrence of
EoE following SCIT. We suggest that the exposure to subcutaneous
aeroallergen immunotherapy induced a similar immune response to
SLIT, resulting in recurrence of EoE. The exact mechanism underlying
this is not fully understood but, in this case, cannot be as a result of the
direct exposure of the allergen on the oesophageal mucosa. Patients with a history of EoE whom are offered immunotherapy (both SCIT
and SLIT) should be counseled about the risk of recurrence of disease.
Further studies are needed to help understand the role of
aeroallergens in the development of EoE and may help to identify
individuals at higher risk.
The possibility of using immunotherapy as a treatment option
for EoE in children has been described [9] but requires a better
understanding of the disease, and further studies, before this could
be a realistic option.
Eosinophilic esophagitis (EoE) is an emerging clinicopathologic
entity defined by abnormal esophageal eosinophilic infiltration.
Management of this disease is hampered by limited understanding
of etiologic and controllable risk factors. The aim of this systematic
review was to determine the environmental risk factors for EoE.
We searched the PubMed, Web of Science, and EMBASE databases
from January 1, 1950, through June 30, 2015. To identify additional
relevant studies, we had searched bibliographies of included articles.
We limited the review to articles using human subjects and consisting
of case reports, case series, cross-sectional and cohort studies, and
clinical trials. Nineteen articles discuss the risk of environmental
exposures on EoE and indicate that environment plays a large role
in the etiology of EoE. Seasonal, geographic, and climate-based
differences in disease prevalence have been reported, but the exact
mediators of this process, possibly aeroallergens that vary over time
and from place to place, remain elusive.
Background 1
Seasonal variation has been reported in diagnosis of eosinophilic
oesophagitis (EoE), but results are not consistent across studies and
there are no national-level data in the USA. AIM: To determine if
there is seasonal variation in diagnosis of oesophageal eosinophilia
and EoE in the USA, while accounting for factors such as climate zone
and geographic variation.
Methods
This was a cross-sectional study using a USA national pathology
database. Patients with oesophageal eosinophilia (>/=15 eosinophils
per high-power field) comprised the primary case definition and were
compared to those with normal oesophageal biopsies. We calculated
the crude and adjusted odds of oesophageal eosinophilia by season, as
well as by day of the year. Sensitivity analyses were performed using
more restrictive case definitions of EoE, and after stratification by
climate zone.
Results
Exactly, 14 524 cases with oesophageal eosinophilia and 90 459
normal controls were analyzed. The adjusted odds of oesophageal
eosinophilia were higher in the late spring and summer months,
with the highest odds in July (a OR: 1.13; 95% CI: 1.03-1.24). These
findings persisted with increasing levels of oesophageal eosinophilia,
as well as across EoE case definitions. Seasonal variation was strongest
in temperate and cold climates, and peak diagnosis varied by climate
zone.
Conclusions
There is a mild but consistent seasonal variation in the diagnosis
of oesophageal eosinophilia and EoE, with cases more frequently
diagnosed during summer months. These findings take into account
climate and geographic differences, suggesting that aeroallergens may
contribute to disease development or flare.
Background 2
The onset of eosinophilic esophagitis (EoE) after oral
immunotherapy (OIT) has been repeatedly described in patients with
immunoglobulin E (IgE)-mediated food allergy in recent years, but
the relation between the 2 conditions has not been fully assessed and
quantified.
Objective
To provide a systematic review of the evidence for an association
between OIT and EoE.
Methods
Electronic searches were performed with keywords relating to
EoE and OIT in the MEDLINE, EMBASE, and SCOPUS databases.
Summary estimates were calculated. A fixed-effects model was used
depending on heterogeneity (I (2)). Risk of publication bias was
assessed by funnel plot analysis and the Egger test.
Results
The search yielded 118 documents, 15 of which were included
in the quantitative summary. Most reported information came
from children undergoing peanut, milk, and egg OIT. Significant
publication bias in favor of studies reporting the development of EoE
after OIT was documented. The overall prevalence of EoE after OIT
was 2.7% (95% confidence interval 1.7%-4.0%, I (2) = 0%). Differences
between medium-to high-quality studies and those of low quality
were documented (3.5% vs. 2.5%, respectively). EoE often resolved
after OIT discontinuation; histologic remission of EoE achieved after
allergen immunotherapy also was documented in 2 patients whose
topical fluticasone treatment failed.
Conclusion
New onset of EoE after OIT occurs in up to 2.7% of patients with
IgE-mediated food allergy undergoing this treatment strategy. The
limited data on the utility of allergen immunotherapy as a therapy for
EoE prevent a recommendation for this treatment option.
Eosinophilic esophagitis (EoE) may affect humans at any age with
a predominance for Caucasian males. The clinical manifestation of
EoE varies depending on the patient's age. Infants and young children
may primarily present with unspecific symptoms such as feeding
problems, vomiting and abdominal pain. In adolescents and adults,
dysphagia and food impactation become the predominant symptoms.
EoE should also be considered in cases of refractory heartburn in both
children and adults. Concomitant allergic diseases such as asthma,
rhinitis and eczema, as well as peripheral eosinophilia and elevated
total serum IgE values are common in pediatric and adult EoE patients.
EoE seems to be primarily a food antigen-driven disease, whereas in
adults, aeroallergen sensitization may dominate. Endoscopic features
of EoE include mucosal edema, furrows, exudates, corrugated rings,
strictures, and the so-called crepe paper sign. There appears to be
a shift from an inflammatory-predominant phenotype in young
childhood towards a more fibrotic phenotype in adolescents and
adults. Long-term follow studies suggest that EoE is a chronic and
potentially progressive disease causing recurring dysphagia in the
majority of cases. The prevalence of strictures significantly increases
with the duration of untreated disease, stressing the importance of
early diagnosis and consequent treatment of EoE.
Sublingual immunotherapy (SLIT) is increasingly investigated
and utilized for the treatment of food and pollen allergies. Previous
case reports suggested that eosinophilic esophagitis (EoE) might develop as a long-term complication in children after completion
of oral immunotherapy. Here, we describe a 44-year-old female
with a medical history of pollinosis who for the first time in her life
developed complete manifestation of EoE (peak eosinophils 164/high
power field) 4 weeks after initiation of SLIT using specific soluble
allergens (hazelnut, birch, alder) according to previous specific serum
IgE testing. After discontinuation of SLIT, EoE resolved completely
within 4 weeks without any other medical intervention. During a
follow-up of 12 months the patient remained free of any esophageal
symptoms. This is the first case report demonstrating a close and
therefore likely causative association between pollen SLIT and EoE
in an adult patient.
Eosinophil infiltration into the esophagus is observed in diverse
diseases including gastroesophageal reflux and allergic gastroenteritis,
but the processes involved are largely unknown. We now report an
original model of experimental esophagitis induced by exposure
of mice to respiratory allergen. Allergen-challenged mice develop
marked levels of esophageal eosinophils, free eosinophil granules, and
epithelial cell hyperplasia, features that mimic the human disorders.
Interestingly, exposure of mice to oral or intra gastric allergen does
not promote eosinophilic esophagitis, indicating that hypersensitivity
in the esophagus occurs with simultaneous development of
pulmonary inflammation. Furthermore, in the absence of eotaxin,
eosinophil recruitment is attenuated, whereas in the absence of IL-
5, eosinophil accumulation and epithelial hyperplasia are ablated.
These results establish a pathophysiological connection between
allergic hypersensitivity responses in the lung and esophagus and
demonstrate an etiologic role for inhaled allergens and eosinophils in
gastrointestinal inflammation.
Background 3
Evidence supports a possible link between eosinophilic
esophagitis (EoE) and environmental aeroallergens, which can
manifest as seasonal exacerbation of esophageal eosinophilia. Few
studies have examined this link in pediatric patients with EoE.
Objective
To identify the proportion of patients with seasonal induced
esophageal eosinophilia.
Methods
A retrospective chart review was conducted of all patients
diagnosed with EoE at the authors' institution. Demographic data
were collected by chart review. Seasonal variation or flare was defined
as a change from fewer than to at least 15 eosinophils per high-power
field and a minimum of a 2-fold increase in eosinophil count between
2 consecutive biopsy specimens in different seasons without dietary
or medication modifications.
Results
Of the 1,180 patients with EoE, 160 (14%) were suspected of having
aeroallergen-associated triggers by history. Of these 160 patients, 32
(20%) had biopsy examination-confirmed variation of EoE triggered
by aeroallergens. Most of these patients were boys (84%), all had a
history or examination consistent with allergic rhinitis, and most had
a history of asthma (75%). Thirty-two subjects had obvious seasonal
variation, 22 of whom also had known food-induced symptoms.
Conclusion
Children with EoE and allergic rhinitis might have exacerbations
in their esophageal eosinophilia during certain seasons depending on the specific aeroallergens to which they are sensitized. Identification
of environmental allergens to sensitized patients is important and can
guide therapy.
Purpose of Review
Eosinophilic esophagitis is a recently recognized disorder receiving increasing attention. Patients present with symptoms of gastroesophageal reflux and are not responsive to standard or aggressive reflux medications. This article reviews all literature published in English from December 2005 to November 2006 from PubMed on the topic of eosinophilic esophagitis.
Recent Findings
Three articles have confirmed that food allergies are causative in more than 90% of patients. Three different diet strategies were used: elemental, elimination diet based on the prick-skin test, and the atopy patch test or removal of the six most common foods. The elemental diet had the highest success rate (> 95%), whereas the testing-based elimination diet (> 75%) and six-food elimination diet (> 70%) had lower success rates. There are no organized dietary trials in adults.
Summary
Recent literature on pediatric patients with eosinophilic esophagitis confirms that nearly all patients respond to an elemental diet with resolution of symptoms and normalization of biopsies. Although diets based on testing or removal of the most common allergens showed success, they were less successful than a complete elimination diet. Unfortunately, there are very limited studies in adults that address this issue.
References
- Miehlke S. "Clinical features of Eosinophilic esophagitis in children and adults". Best Pract Res Clin Gastroenterol. 2015; 29: 739-748.
- Spergel JM. "Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients". Curr Opin Allergy Clin Immunol. 2007; 7: 274-278.
- Mishra A, Simon P Hogan, Eric B Brandt, Marc E Rothenberg. "An etiological role for aeroallergens and eosinophils in experimental esophagitis". J Clin Invest. 2001; 107: 83-90.
- Green DJ, Cotton CC, Dellon ES. "The Role of Environmental Exposures in the Etiology of Eosinophilic Esophagitis: A Systematic Review". Mayo Clin Proc. 2015; 90: 1400-1410.
- Jensen ET, Neil D Shah, Kate Hoffman, Amnon Sonnenberg, Robert M Genta, Evan S Dellon. "Seasonal variation in detection of oesophageal eosinophilia and eosinophilic oesophagitis". Aliment Pharmacol Ther. 2015; 42: 461-469.
- Ram G, Lee J, Ott M, Brown-Whitehorn TF, Cianferoni A, Shuker M, et al. "Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis". Ann Allergy Asthma Immunol. 2015; 115: 224-228.e221.
- Lucendo AJ, Arias A, Tenias JM. "Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis". Ann Allergy Asthma Immunol. 2014; 113: 624-629.
- Miehlke S, Oral Alpan, Sören Schröder, Alex Straumann. "Induction of eosinophilic esophagitis by sublingual pollen immunotherapy." Case Rep Gastroenterol. 2013; 7: 363-368.
- Ramirez RM, RL Jacobs. "Eosinophilic esophagitis treated with immunotherapy to dust mites". J Allergy Clin Immunol. 2013; 132: 503- 504.